Table 1.
Untreated group | IVM treated group+ | |||
---|---|---|---|---|
Cycle 1 | Cycle 2 | Cycle 1 | Cycle 2 | |
No IVM (n = 163) | No IVM (n = 163) | No IVM (n = 43) | With IVM (n = 43) | |
Mean age (years)* | 36.8 ± 4.3 | 37.3 ± 4.3 | 36.4 ± 4.4 | 36.9 ± 4.4 |
Mean BMI (kg/m2)** | 25.6 ± 6.2 | 25.4 ± 6.1 | 25.9 ± 5.8 | 26.0 ± 5.8 |
< 18.5 | 7 (4.4) | 7 (4.3) | 1 (2.3) | 1 (2.4) |
18.5–24.9 | 89 (56.0) | 94 (57.7) | 22 (51.2) | 21 (50.0) |
25.0–29.9 | 32 (20.1) | 31 (19.0) | 10 (23.3) | 10 (23.8) |
30.0–39.9 | 24 (15.1) | 24 (14.7) | 8 (18.6) | 8 (19.1) |
≥ 40 | 7 (4.4) | 7 (4.3) | 2 (4.7) | 2 (4.8) |
Race/ethnicity** | ||||
Caucasian | 112 (68.7) | 113 (69.3) | 21 (48.8) | 22 (51.2) |
Black or African-American | 10 (6.1) | 10 (6.1) | 4 (9.3) | 4 (9.3) |
Asian | 10 (6.1) | 10 (6.1) | 7 (16.3) | 8 (18.6) |
Hispanic | 8 (4.9) | 8 (4.9) | 1 (2.3) | 1 (2.3) |
Other | 3 (1.8) | 3 (1.8) | 1 (2.3) | 1 (2.3) |
Unknown | 20 (12.2) | 19 (11.7) | 9 (21.0) | 8 (18.6) |
Diagnosis **++ | ||||
Tubal factor | 19 (11.7) | 20 (12.3) | 1 (2.3) | 1 (2.3) |
Uterine factor | 7 (4.3) | 7 (4.3) | 1 (2.3) | 1 (2.3) |
Endometriosis | 11 (6.8) | 11 (6.8) | 1 (2.3) | 1 (2.3) |
Ovulatory | 17 (10.4) | 17 (10.4) | 3 (6.7) | 2 (4.7) |
DOR | 47 (28.8) | 49 (30.1) | 8 (18.6) | 9 (20.9) |
Unexplained | 40 (24.5) | 40 (24.5) | 15 (34.9) | 16 (37.2) |
Male | 51 (31.3) | 50 (30.7) | 16 (37.2) | 16 (37.2) |
Other | 27 (16.6) | 28 (17.2) | 5 (11.6) | 5 (11.6) |
Gravid | 73 (44.8) | 85 (52.2) | 25 (58.1) | 24 (55.8) |
Parous | 34 (20.9) | 34 (20.9) | 9 (20.9) | 9 (20.9) |
D3 FSH (mIU/mL)* | 9.0 ± 5.5 | 9.2 ± 6.0 | 8.2 ± 4.2 | 7.8 ± 3.6 |
D3 estradiol (pg/mL)* | 42.1 ± 22.8 | 40.7 ± 23.1 | 34.2 ± 23.2 | 34.4 ± 23.0 |
AMH (ng/mL)* | 4.3 ± 7.7 | 4.4 ± 7.7 | 2.7 ± 2.1 | 2.6 ± 2.1 |
Cycle number* | 1.2 ± 0.5 | 2.2 ± 0.5 | 2.0 ± 1.1 | 3.0 ± 1.1 |
+Defined by women who undergo IVM in cycle 2
*Values are mean ± SD
**Vales are number (% total)
++Some women possess multiple diagnoses and thus, these values do not add to 100%